Cases – Page 54 – ClaimsFiler

Recent Security Class Actions

Athira Pharma, Inc. describes itself as a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration for those suffering from devastating neurological diseases, including Alzheimer’s disease. The Company’s product candidates aim to provide rapid cognitive improvement and alter the course of neurological diseases with their novel mechanism of action.

Home Point Capital Inc., together with its subsidiaries, operates as a residential mortgage originator and service provider. The Company operates through two segments, Origination and Servicing. The Origination segment sources loans through direct, wholesale, and correspondent channels. The Servicing segment offers collecting loan payments; remitting principal and interest payments to investors; managing escrow funds for the payment of mortgage-related expenses, such as taxes and insurance; and performing loss mitigation activities on behalf of investors and administering mortgage loans. On January 8, 2021, Home Point filed a registration statement on Form S-1 with the SEC in connection with the IPO, which, after amendment, was declared effective on January 28, 2021.

Ocugen, Inc identifies itself as a biopharmaceutical company focused on developing gene therapies to cure blindness and developing a vaccine to save lives from COVID-19. The company’s main developments are a modifier gene therapy platform based on nuclear hormone receptors (“NHRs”) to generate therapies for patient with inherited retinal diseases (“IRDs”) and dry age-related macular degeneration (“AMD”).

Natural-gas producer EQT drills for gas primarily in Pennsylvania, West Virginia and Ohio, utilizing the practice of “fracking” to extract gas from shale deposits.  EQT sought to acquire a rival company, Rice by way of a merger (the “Rice Acquisition” or “Acquisition”). Rice held various tracts of lands adjacent to EQT’s property.  The Rice Acquisition, announced on June 19,  2017,  would  expand  the  total  acreage  available  for  EQT’s  drilling  and  fracking.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company that focuses on the development and commercialization of therapies for the treatment of acute pain. The Company’s lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-tosevere acute pain. DSUVIA is a potent opioid painkiller that is of particular use in certain special circumstances where adult patients may not be able to swallow oral medication and where access to intravenous pain relief is not possible.

Nutanix, Inc. purports to be a cloud computing software company headquartered in San Jose, California known for pioneering its “core” hyper-converged infrastructure (“HCI”) software technology, which combines the components of data center computing (server, storage, and virtualization) into a single scalable machine through software.

Nuance Communications, Inc. is a pioneer and a leading provider of conversational AI and cloud-based ambient clinical intelligence for healthcare providers. Nuance’s products include the Dragon Ambient eXperience, Dragon Medical One and PowerScribe One for radiology reporting, all leading clinical speech recognition SaaS offerings built on Microsoft Azure.

GW Pharmaceuticals, PLC is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from their proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world’s first plant-derived cannabinoid prescription drug, Sativex, which is approved for the treatment of spasticity due to multiple sclerosis in 25 countries. The Company has two primary, more developed products: Epidiolex and Nabiximols (Sativex). GW also has a deep pipeline of additional cannabinoid product candidates and novel compounds, including compounds in Phase 1, Phase 2, and Phase 3 trials.

Washington Prime Group, Inc. is a self-managed and self-administered real estate investment trust (“REIT”) that owns properties and conducts operations through Washington Prime Group, L.P.

Provention Bio, Inc. is a clinical stage biopharmaceutical company that focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. The Company’s product candidates include, among others, PRV-031 teplizumab and mAb, in Phase III clinical trial for the interception of T1D.

Ubiquiti Inc. develops and markets equipment and technology platforms for high capacity Internet access, unified information technology, and consumer electronics.

ContextLogic Inc. is a San Francisco-based, global mobile ecommerce company that operates the Wish platform that connects its value-conscious user base to merchants. Founded in 2010, Wish is a global e-commerce platform that generates revenue by charging merchants a commission on sales made in its marketplace. The Company also generates fees by offering advertising and logistics services to its merchants. With a large range of beauty, clothing and electronics products sold at wholesale prices, Wish claims to have managed to swiftly garner a user base of 100 million monthly active users and 500,000 merchants.

Array Technologies, Inc. describes itself as one of the world’s largest manufacturers of groundmounting systems used in solar energy projects. The Company's principal products are commonly referred to as "trackers." Trackers are designed to move solar panels throughout the day to maintain an optimal orientation to the sun, which significantly increases their energy production.

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK